Molecular Mechanisms that govern the antitumor response of CAR T therapies in MM at the single cell level (CARMM2)

Project information

The project “Molecular Mechanisms Governing the Antitumor Response of CAR T Therapies in Multiple Myeloma at Single-Cell Resolution” is a project of the Immunotherapy Group within the Hematology-Oncology Program.

Project PID2022-137914OB-I00 funded by:

• Convocation: Proyectos de Generación de Conocimiento 2022
• Reference: PID2022-137914OB-I00
• Duration: 36
• Start date: September 1, 2023
• End date: August 31, 2026
• Nature of project: National